press releases and company news

Press releases& company news

Crassula Pharmaceuticals publishes its latest announcements here: science-driven breakthroughs such as the QuanticSphere™ delivery platform, product launches in Honduras, partnerships, appointments and regulatory milestones. Assets and spokespeople are available for accredited media through the press office.

press@crassulapharma.comnews@crassulapharma.com
01 Latest release

Latest news

Science-driven breakthroughs, partnerships and regulatory milestones from Crassula Pharmaceuticals.

q niflex pqns

Q-NiFlex™ and Phytosome Quantum Nano Sphere (PQNS™) Technology: A Next-Generation Multi-Target Drug Delivery Strategy for Joint Health and Osteoarthritis Management

A peer-reviewed paper in the International Journal of Scientific Research (Vol. 15, Issue 7, July 2026) outlines the multi-target formulation and nano-delivery mechanism; a 500-patient randomized controlled trial is underway to evaluate clinical outcomes.

Read the release →

02 Archive

All releases

  • Science & technology

Crassula Launches Q-Niflex™ — a Joint & Cartilage-Health Dietary Supplement Powered by Integria Care’s QuanticSphere™ Delivery Platform

Introduced at an event in Indore, India, Q-Niflex™ is the first finished consumer product to bring the QuanticSphere™ delivery platform to the Indian supplement market.
Crassula Pharmaceuticals launches QuanticSphere technology in India
  • Greetings

Happy Diwali

Wishing renewed energy, health and prosperity to every home, with the same spirit of clarity and purpose that guides our work in science and wellness.
Happy Diwali
  • Greetings

Season’s Greetings from Crassula

A thank-you to the clients, partners and community who trusted us with their well-being during another year of milestones and new partnerships.
Crassula 2025v1
  • Greetings

India Independence Day

Celebrating India’s 78th Independence Day and the resilience, unity and spirit of its people.
India Independence Day
  • Product launches

Crassula Launches Vascutan Plus, Irbesartan/Hydrochlorothiazide, in Honduras

A combination of an angiotensin II receptor blocker and a thiazide diuretic that broadens Crassula’s hypertension portfolio in Honduras.
Vascutan Plus 30025
  • Product launches

Crassula Pharmaceuticals Launches Vascutan, Irbesartan, in Honduras

The market introduction of Vascutan expands Crassula’s cardiovascular portfolio for hypertension and associated cardiac conditions.
Vascutan 300mg 30 Tabs 1
  • Company

We are proud to announce a new addition to our team at CRASSULA!

Daniel Suazo joins Crassula Honduras as Medical Representative Lead, bringing a strong background in the healthcare sector.
WhatsApp Image 2024 04 16 at 150426
  • Product launches

Introducing Glycedil: Revolutionizing Type 2 Diabetes Management in Honduras

Crassula Honduras expands its diabetes care portfolio with the launch of Glycedil, a sitagliptin 100 mg tablet.
Glycedil 100mg
  • Product launches

Crassula Launches Relixib, Etoricoxib 120mg Coated Tablet, in Honduras

Relixib joins the portfolio to address the needs of patients with chronic pain and inflammation.
Relixib 120mg Comp
  • Company

Dr. Bhavana Gupta

Dr. Gupta leads the company’s technical operations, including research and development, and serves as technical advisor to the CEO.
Welcome Team B G
  • Health awareness

Cancer Remains A Threat In The Society

An overview of how cancer develops and why it remains a growing health concern.
Jan 25 Promoting Compassion and Understanding for World Cancer Day
  • Health awareness

Noncommunicable diseases (NCDs)

Cancer, heart disease and diabetes are among the most prevalent and fastest-growing health issues worldwide.
doctors
  • Product launches

Crassula Pharma Lauches In Honduras

Gasflum expands Crassula Honduras’ portfolio for the management of acid reflux and related conditions.
Gasflum - Esomeprazol
03 Media contact

Press office

Assets and spokespeople are available for accredited media.

Press

Media enquiries

press@crassulapharma.com

News

Latest releases

news@crassulapharma.com

Media kit

Logos & assets

Download media kit (PDF)